Investors hunting for high-growth opportunities in 2026 are increasingly looking beyond headline-grabbing private companies like SpaceX toward listed alternatives.
SpaceX remains one of the most talked-about private companies in the world, but its inaccessibility to ordinary investors is a persistent source of frustration for retail portfolios.
The FTSE 250 index, often overshadowed by its larger FTSE 100 counterpart, continues to harbour genuinely exciting growth stories that are available to any investor with a brokerage account.
Unlike SpaceX, which remains privately held and valued at extraordinary multiples, FTSE 250 stocks offer liquidity, regulatory transparency, and the ability to buy and sell shares freely on public markets.
Private company valuations can also be difficult to verify with precision, as they are not subject to the same rigorous disclosure requirements that govern publicly listed firms in the UK.
For growth-focused investors, the FTSE 250 provides exposure to mid-cap companies that often sit in a sweet spot between the stability of large caps and the speculative risk of early-stage ventures.
Many of these businesses operate in sectors that are expanding rapidly, including technology, healthcare, and clean energy, giving investors diversified routes into long-term structural growth themes.
The index has historically delivered strong long-term returns, and analysts frequently argue it is underappreciated relative to global mid-cap benchmarks from the United States or continental Europe.
Investors comparing listed equities to private market opportunities must also weigh the premium often attached to the narrative and brand recognition that surrounds companies like SpaceX.
With UK equities continuing to trade at what many fund managers describe as attractive valuations relative to American peers, the FTSE 250 may present a timely opportunity for growth-oriented portfolios in 2026.